200 related articles for article (PubMed ID: 18796496)
1. Global liver proteomics of rats exposed for 5 days to phenobarbital identifies changes associated with cancer and with CYP metabolism.
Dail MB; Shack LA; Chambers JE; Burgess SC
Toxicol Sci; 2008 Dec; 106(2):556-69. PubMed ID: 18796496
[TBL] [Abstract][Full Text] [Related]
2. Proteomic and Bioinformatics Analysis of Membrane Lipid Domains after Brij 98 Solubilization of Uninduced and Phenobarbital-Induced Rat Liver Microsomes: Defining the Membrane Localization of the P450 Enzyme System.
Reed JR; Guidry JJ; Backes WL
Drug Metab Dispos; 2022 Apr; 50(4):374-385. PubMed ID: 35094979
[TBL] [Abstract][Full Text] [Related]
3. Zonal differences in DNA synthesis activity and cytochrome P450 gene expression in livers of male F344 rats treated with five nongenotoxic carcinogens.
Chen ZY; White CC; He CY; Liu YF; Eaton DL
J Environ Pathol Toxicol Oncol; 1995; 14(2):83-99. PubMed ID: 9372837
[TBL] [Abstract][Full Text] [Related]
4. Proteome studies on liver tissue in a phenobarbital-induced rat model.
Wu Q; Zhang YH; Zhao X; Shi WL; Pu XP
Eur J Pharmacol; 2011 Nov; 670(2-3):333-40. PubMed ID: 21968144
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of GADD45 genes during the development of chemical-mediated liver hypertrophy and liver tumor promotion in rats.
Ozawa S; Gamou T; Habano W; Inoue K; Yoshida M; Nishikawa A; Nemoto K; Degawa M
J Toxicol Sci; 2011 Oct; 36(5):613-23. PubMed ID: 22008536
[TBL] [Abstract][Full Text] [Related]
6. Effects of monoterpenoids on in vivo DMBA-DNA adduct formation and on phase I hepatic metabolizing enzymes.
Maltzman TH; Christou M; Gould MN; Jefcoate CR
Carcinogenesis; 1991 Nov; 12(11):2081-7. PubMed ID: 1934293
[TBL] [Abstract][Full Text] [Related]
7. Induction by Phenobarbital of Phase I and II Xenobiotic-Metabolizing Enzymes in Bovine Liver: An Overall Catalytic and Immunochemical Characterization.
Cantiello M; Carletti M; Giantin M; Gardini G; Capolongo F; Cascio P; Pauletto M; Girolami F; Dacasto M; Nebbia C
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408925
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics of cytochrome P450 2B induction by phenobarbital, 5-ethyl-5-phenylhydantoin, and 5-ethyl-5-phenyloxazolidinedione in the male rat liver or in cultured rat hepatocytes.
Nims RW; Sinclair PR; Sinclair JF; Thomas PE; Jones CR; Mellini DW; Syi JL; Lubet RA
Chem Res Toxicol; 1993; 6(2):188-96. PubMed ID: 8477010
[TBL] [Abstract][Full Text] [Related]
9. Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters.
Neveu MJ; Babcock KL; Hertzberg EL; Paul DL; Nicholson BJ; Pitot HC
Cancer Res; 1994 Jun; 54(12):3145-52. PubMed ID: 8205533
[TBL] [Abstract][Full Text] [Related]
10. A mechanism-based integrated pharmacokinetic enzyme model describing the time course and magnitude of phenobarbital-mediated enzyme induction in the rat.
Magnusson MO; Karlsson MO; Sandström R
Pharm Res; 2006 Mar; 23(3):521-32. PubMed ID: 16525862
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of cytochrome(s) P450 2B1/2 by phenobarbital in hepatic hyperplastic nodules induced by aflatoxin B1 or diethylnitrosamine plus 2-acetylaminofluorene in male F344 rats.
Chen ZY; Eaton DL
Toxicol Appl Pharmacol; 1991 Oct; 111(1):132-44. PubMed ID: 1949030
[TBL] [Abstract][Full Text] [Related]
12. Effect of Cimetidine and Phenobarbital on metabolite kinetics of Omeprazole in rats.
Park EJ; Cho HY; Lee YB
Arch Pharm Res; 2005 Oct; 28(10):1196-202. PubMed ID: 16276979
[TBL] [Abstract][Full Text] [Related]
13. Molecular and pharmacokinetic evaluation of rat hepatic and gastrointestinal cytochrome p450 induction by tamoxifen.
Cotreau MM; von Moltke LL; Harmatz JS; Greenblatt DJ
Pharmacology; 2001; 63(4):210-9. PubMed ID: 11729359
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of cytochrome P450 mRNAs and related steroid hydroxylation activities in hepatic hyperplastic nodules in male F344 rats.
Chen ZY; White CC; Eaton DL
Toxicol Appl Pharmacol; 1993 Nov; 123(1):151-9. PubMed ID: 8236254
[TBL] [Abstract][Full Text] [Related]
15. Induction of cytochrome P450 isozymes by phenobarbital in pregnant rat and fetal livers and placenta.
Ejiri N; Katayama K; Doi K
Exp Mol Pathol; 2005 Apr; 78(2):150-5. PubMed ID: 15713442
[TBL] [Abstract][Full Text] [Related]
16. Effects of cytochrome P450 inducers on I-compounds in rat liver and kidney DNA.
Li D; Moorthy B; Chen S; Randerath K
Carcinogenesis; 1992 Jul; 13(7):1191-8. PubMed ID: 1638686
[TBL] [Abstract][Full Text] [Related]
17. Feed-drug interaction of orally applied butyrate and phenobarbital on hepatic cytochrome P450 activity in chickens.
Mátis G; Kulcsár A; Petrilla J; Hermándy-Berencz K; Neogrády Z
J Anim Physiol Anim Nutr (Berl); 2016 Aug; 100(4):637-42. PubMed ID: 26614344
[TBL] [Abstract][Full Text] [Related]
18. Phenobarbital enhances the formation of reactive oxygen in neoplastic rat liver nodules.
Scholz W; Schütze K; Kunz W; Schwarz M
Cancer Res; 1990 Nov; 50(21):7015-22. PubMed ID: 2208168
[TBL] [Abstract][Full Text] [Related]
19. Acitretin elimination in Sprague-Dawley rats pretreated with phenobarbital or beta-naphthoflavone.
Small DS; McNamara PJ
Drug Metab Dispos; 1995 Apr; 23(4):465-72. PubMed ID: 7600913
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of propylthiouracil, amiodarone, diphenylhydantoin, phenobarbital, and 3-methylcholanthrene on hepatic and renal T4 metabolism and thyroid gland function in rats.
De Sandro V; Chevrier M; Boddaert A; Melcion C; Cordier A; Richert L
Toxicol Appl Pharmacol; 1991 Nov; 111(2):263-78. PubMed ID: 1957312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
